One of India's leading drug maker Cipla said it took a charge of around Rs 40 crore in Q4FY22 on its forex line, on account of receivables from Sri Lanka.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/lmXtD4j
via IFTTT
One of India's leading drug maker Cipla said it took a charge of around Rs 40 crore in Q4FY22 on its forex line, on account of receivables from Sri Lanka.
No comments:
Post a Comment